Skip to main content
Erschienen in: World Journal of Pediatrics 5/2021

28.09.2021 | COVID-19 | Editorial Zur Zeit gratis

COVID-19 in children and the importance of COVID-19 vaccination

verfasst von: Feng-Xia Xue, Kun-Ling Shen

Erschienen in: World Journal of Pediatrics | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Excerpt

As of August 30, 2021, COVID-19 has caused more than 216 million infections and 4.49 million deaths worldwide, with 0.58 million new cases [1]. Because the COVID-19 vaccine is distributed gradually and widely, the development of the global epidemic has been prevented to some extent, but the emergence of SARS-CoV-2 variants makes us worried. The alpha (B.1.1.7), beta (B.1.351), gamma (P.1) and delta (B.1.617) strains have been named variants of concern by the WHO [2]. The SARS-CoV-2 variants have increased in transmissibility and virulence, leading to higher morbidity and mortality. The delta variant has spread to at least 148 countries, territories and areas, as of August 2021, becoming the mainstream virus variant in the world [3]. Compared with the elderly, people with chronic diseases, and health care providers, children are seen as a low-priority age group for vaccination, making them become the largest unvaccinated population currently. We aimed to review the latest epidemiological evidence, and elucidate the importance of COVID-19 vaccination for children. …
Literatur
4.
Zurück zum Zitat Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.CrossRef Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.CrossRef
5.
Zurück zum Zitat Ladhani SN, Amin-Chowdhury Z, Davies HG, Aiano F, Hayden I, Lacy J, et al. COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child. 2020;105:1180–5.CrossRef Ladhani SN, Amin-Chowdhury Z, Davies HG, Aiano F, Hayden I, Lacy J, et al. COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child. 2020;105:1180–5.CrossRef
6.
Zurück zum Zitat Kao CM, Orenstein WA, Anderson EJ. The importance of advancing severe acute respiratory syndrome coronavirus 2 vaccines in children. Clin Infect Dis. 2021;72:515–8.CrossRef Kao CM, Orenstein WA, Anderson EJ. The importance of advancing severe acute respiratory syndrome coronavirus 2 vaccines in children. Clin Infect Dis. 2021;72:515–8.CrossRef
7.
Zurück zum Zitat Hobbs CV, Drobeniuc J, Kittle T, Williams J, Byers P, Satheshkumar PS, Inagaki K, Stephenson M, Kim SS, Patel MM, Flannery B, CDC COVID-19 Response Team. Estimated SARS-CoV-2 seroprevalence among persons aged 18 years- Mississippi, May-September 2020. MMWR Morb Mortal Wkly Rep. 2021;70:312–5.CrossRef Hobbs CV, Drobeniuc J, Kittle T, Williams J, Byers P, Satheshkumar PS, Inagaki K, Stephenson M, Kim SS, Patel MM, Flannery B, CDC COVID-19 Response Team. Estimated SARS-CoV-2 seroprevalence among persons aged 18 years- Mississippi, May-September 2020. MMWR Morb Mortal Wkly Rep. 2021;70:312–5.CrossRef
8.
Zurück zum Zitat Li Z, Guan X, Mao N, Luo H, Qin Y, He N, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021;8:100094.CrossRef Li Z, Guan X, Mao N, Luo H, Qin Y, He N, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021;8:100094.CrossRef
9.
Zurück zum Zitat Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911–9.CrossRef Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911–9.CrossRef
10.
Zurück zum Zitat Loenenbach A, Markus I, Lehfeld AS, An der Heiden M, Haas W, Kiegele M, et al. SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021. Euro Surveill. 2021;26:2100433.CrossRef Loenenbach A, Markus I, Lehfeld AS, An der Heiden M, Haas W, Kiegele M, et al. SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021. Euro Surveill. 2021;26:2100433.CrossRef
11.
Zurück zum Zitat Misra P, Kant S, Guleria R, Rai SK. Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: an interim result from a large multi-centric population-based seroepidemiological study. medRxiv. 2021. (Preprint). Misra P, Kant S, Guleria R, Rai SK. Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: an interim result from a large multi-centric population-based seroepidemiological study. medRxiv. 2021. (Preprint).
14.
Zurück zum Zitat Riley S, Eales O, Haw D, Wang H, Walters CE, Ainslie KEC, et al. REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021. medRxiv. 2021. (Preprint). Riley S, Eales O, Haw D, Wang H, Walters CE, Ainslie KEC, et al. REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021. medRxiv. 2021. (Preprint).
17.
Zurück zum Zitat Preston LE, Chevinsky JR, Kompaniyets L, Lavery AM, Kimball A, Boehmer TK, et al. Characteristics and disease severity of US children and adolescents diagnosed with COVID-19. JAMA Netw Open. 2021;4:e215298.CrossRef Preston LE, Chevinsky JR, Kompaniyets L, Lavery AM, Kimball A, Boehmer TK, et al. Characteristics and disease severity of US children and adolescents diagnosed with COVID-19. JAMA Netw Open. 2021;4:e215298.CrossRef
18.
Zurück zum Zitat Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year. medRxiv. 2021. (Preprint). Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year. medRxiv. 2021. (Preprint).
19.
Zurück zum Zitat Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4:e2111182.CrossRef Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4:e2111182.CrossRef
21.
Zurück zum Zitat Harwood R, Yan H, Da Camara NT, Smith C, Ward J, Tudur-Smith C, et al. Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis. medRxiv. 2021. (Preprint). Harwood R, Yan H, Da Camara NT, Smith C, Ward J, Tudur-Smith C, et al. Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis. medRxiv. 2021. (Preprint).
22.
Zurück zum Zitat Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–46.CrossRef Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–46.CrossRef
23.
Zurück zum Zitat Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347–58.CrossRef Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347–58.CrossRef
27.
Zurück zum Zitat Smith C, Odd D, Harwood R, Ward J, Linney M, Clark M, et al. Deaths in children and young people in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data. medRxiv. 2021. (Preprint). Smith C, Odd D, Harwood R, Ward J, Linney M, Clark M, et al. Deaths in children and young people in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data. medRxiv. 2021. (Preprint).
28.
Zurück zum Zitat Warner S, Richter A, Stamataki Z, Kelly D. Understanding COVID-19: are children the key. BMJ Paediatr Open. 2021;5:e001063.CrossRef Warner S, Richter A, Stamataki Z, Kelly D. Understanding COVID-19: are children the key. BMJ Paediatr Open. 2021;5:e001063.CrossRef
29.
Zurück zum Zitat Abbas K, Mogasale V. Disruptions to childhood immunisation due to the COVID-19 pandemic. Lancet. 2021;398:469–71.CrossRef Abbas K, Mogasale V. Disruptions to childhood immunisation due to the COVID-19 pandemic. Lancet. 2021;398:469–71.CrossRef
30.
Zurück zum Zitat Marchetti F, Tamburlini G. Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations. BMJ. 2021;374:n2052.CrossRef Marchetti F, Tamburlini G. Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations. BMJ. 2021;374:n2052.CrossRef
32.
Zurück zum Zitat Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218-39. e3.CrossRef Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218-39. e3.CrossRef
33.
Zurück zum Zitat Golberstein E, Wen H, Miller BF. Coronavirus disease 2019 (COVID-19) and mental health for children and adolescents. JAMA Pediatr. 2020;174:819–20.CrossRef Golberstein E, Wen H, Miller BF. Coronavirus disease 2019 (COVID-19) and mental health for children and adolescents. JAMA Pediatr. 2020;174:819–20.CrossRef
34.
Zurück zum Zitat Hillis SD, Unwin HJT, Chen Y, Cluver L, Sherr L, Goldman PS, et al. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study. Lancet. 2021;398:391–402.CrossRef Hillis SD, Unwin HJT, Chen Y, Cluver L, Sherr L, Goldman PS, et al. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study. Lancet. 2021;398:391–402.CrossRef
35.
Zurück zum Zitat Santos VS, Gurgel RQ, Cuevas LE, Martins-Filho PR. Prolonged fecal shedding of SARS-CoV-2 in pediatric patients: a quantitative evidence synthesis. J Pediatr Gastroenterol Nutr. 2020;71:150–2.CrossRef Santos VS, Gurgel RQ, Cuevas LE, Martins-Filho PR. Prolonged fecal shedding of SARS-CoV-2 in pediatric patients: a quantitative evidence synthesis. J Pediatr Gastroenterol Nutr. 2020;71:150–2.CrossRef
36.
Zurück zum Zitat Xu CLH, Raval M, Schnall JA, Kwong JC, Holmes NE. Duration of respiratory and gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and synthesis of data. Pediatr Infect Dis J. 2020;39:e249–56.CrossRef Xu CLH, Raval M, Schnall JA, Kwong JC, Holmes NE. Duration of respiratory and gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and synthesis of data. Pediatr Infect Dis J. 2020;39:e249–56.CrossRef
37.
Zurück zum Zitat Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, et al. Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses. J Pediatr. 2020;227:45-52. e5.CrossRef Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, et al. Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses. J Pediatr. 2020;227:45-52. e5.CrossRef
38.
Zurück zum Zitat Lyngse FP, Mølbak K, Træholt Franck K, Nielsen C, Skov RL, Voldstedlund M, et al. Association between SARS-CoV-2 transmissibility, viral load, and age in households. medRxiv. 2021. (Preprint) Lyngse FP, Mølbak K, Træholt Franck K, Nielsen C, Skov RL, Voldstedlund M, et al. Association between SARS-CoV-2 transmissibility, viral load, and age in households. medRxiv. 2021. (Preprint)
39.
Zurück zum Zitat Jones TC, Biele G, Muhlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373:eabi5273.CrossRef Jones TC, Biele G, Muhlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373:eabi5273.CrossRef
40.
Zurück zum Zitat Telle K, Jorgensen SB, Hart R, Greve-Isdahl M, Kacelnik O. Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study. Eur J Epidemiol. 2021;36:741–8.CrossRef Telle K, Jorgensen SB, Hart R, Greve-Isdahl M, Kacelnik O. Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study. Eur J Epidemiol. 2021;36:741–8.CrossRef
42.
Zurück zum Zitat Auger KA, Shah SS, Richardson T, Hartley D, Hall M, Warniment A, et al. Association between statewide school closure and COVID-19 incidence and mortality in the US. JAMA. 2020;324:859–70.CrossRef Auger KA, Shah SS, Richardson T, Hartley D, Hall M, Warniment A, et al. Association between statewide school closure and COVID-19 incidence and mortality in the US. JAMA. 2020;324:859–70.CrossRef
43.
Zurück zum Zitat Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021;21:193–202.CrossRef Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021;21:193–202.CrossRef
44.
Zurück zum Zitat Aiano F, Mensah AA, McOwat K, Obi C, Vusirikala A, Powell AA, et al. COVID-19 outbreaks following full reopening of primary and secondary schools in England: cross-sectional national surveillance, November 2020. Lancet Reg Health Eur. 2021;6:100120.CrossRef Aiano F, Mensah AA, McOwat K, Obi C, Vusirikala A, Powell AA, et al. COVID-19 outbreaks following full reopening of primary and secondary schools in England: cross-sectional national surveillance, November 2020. Lancet Reg Health Eur. 2021;6:100120.CrossRef
45.
Zurück zum Zitat Stein-Zamir C, Abramson N, Shoob H, Libal E, Bitan M, Cardash T, et al. A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020. Euro Surveill. 2020;25:2001352.CrossRef Stein-Zamir C, Abramson N, Shoob H, Libal E, Bitan M, Cardash T, et al. A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020. Euro Surveill. 2020;25:2001352.CrossRef
49.
Zurück zum Zitat Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;S1473–3099:00319–24. Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;S1473–3099:00319–24.
50.
Zurück zum Zitat Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Should children get COVID vaccines? What the science says. Nature. 2021;595:638–9.CrossRef Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Should children get COVID vaccines? What the science says. Nature. 2021;595:638–9.CrossRef
51.
Zurück zum Zitat Gurdasani D, Bhatt S, Costello A, Denaxas S, Flaxman S, Greenhalgh T, et al. Vaccinating adolescents in England-a risk-benefit analysis. OSF Preprints. 2021. (Preprint). Gurdasani D, Bhatt S, Costello A, Denaxas S, Flaxman S, Greenhalgh T, et al. Vaccinating adolescents in England-a risk-benefit analysis. OSF Preprints. 2021. (Preprint).
54.
Zurück zum Zitat Hause AM, Gee J, Baggs J, Abara WE, Marquez P, Thompson D, et al. COVID-19 vaccine safety in adolescents aged 12–17 years - United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1053–8.CrossRef Hause AM, Gee J, Baggs J, Abara WE, Marquez P, Thompson D, et al. COVID-19 vaccine safety in adolescents aged 12–17 years - United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1053–8.CrossRef
55.
Zurück zum Zitat Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977–82.CrossRef Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977–82.CrossRef
Metadaten
Titel
COVID-19 in children and the importance of COVID-19 vaccination
verfasst von
Feng-Xia Xue
Kun-Ling Shen
Publikationsdatum
28.09.2021
Verlag
Springer Singapore
Schlagwort
COVID-19
Erschienen in
World Journal of Pediatrics / Ausgabe 5/2021
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-021-00466-5

Weitere Artikel der Ausgabe 5/2021

World Journal of Pediatrics 5/2021 Zur Ausgabe

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.